



294A ABSTRACTS- Myocardial Ischemia and Infarction 
(reduced fibrinolytic + ptatelet glycoprotein lib/Ilia inhibitor) in this setting is unknown. 
Methods: In the GUSTO V trial, 553 patients with history of prior CABG were treated with 
standard-dose retaplase (n=273) or haft-dose reteplase and full--dose aboiximab (n=280) 
in the first 6 h of evolving ST-segment elevation myocardial infarction. Results: Mortality 
at 30-days was significantly higher in patients with prior CABG compared to patients 
without prior CABG (6.85% vs 5.6%, p=0.003). Despite having more diabetes, hypercho- 
lesterolemia nd longer time to treatment, patients with previous CABG undergoing com- 
bination therapy had fewer episodes of recurrent ischemia, reinfarction, with the 
combination than with rataplase alone, and less need for urgent revascularizafion. Con- 
clusions: In the GUSTO V trial patients with prior CABG had significantly higher event 
rates compared to patients without CABG. As in the overall trial, combination therapy in 
patients with prior CABG led to a consistent reduction in key secondary complications of 
myocardial infarction including recurrent ischemia, reinfarction, and urgent revasculariza- 
tion. 
Clinical outcomes in patients with prior CABG 
CABG CABG No CABG No CABG 
(Retaplase)(R~eplase+(Reteplase) (Retaplase+ 
n=273 Abciximab) n=7924 Abciximab)n=7981 
n=280 
Age 65±10 66±9.7 61±12.2 62±12.1 
Diabetes 20.7% 26.1% 15.7% 15.8% 
Hypercholestrofemia 53.6% 59.2% 15.1% 16.1% 
Time to treatment (hours) 2.9 ±1.7 3.2 ± 2.4 2.9 ±1.6 3.0 ± 2,1 
Death (7 days) 6.6% 5.7% 4.4% 4.2% 
Daath/MI (7 days) 11.7% 9.6% 7.3% 6.1% 
Death (30 days) 8.8% 8.9% 5.8% 5.4% 
Reinfarction 6.2% 4.6% 3.4% 2.2% 
Urgent revasc (7 day) 16.5% 11.1% 13.8% 10.3% 
Death/MI/urgent revasc (7 day) 24.2% 19.3% 19.1% 15.0% 
Recurrent ischemia 21.6% 14.3%* 12.5% 11,2% 
*p<0.05 
1075-28 Early and Late Survival Following Primary PTCA for 
Acute Myocardial Infarction in Patients With Saphenous 
Vein Graft Occlusion 
Bruce R. Brodie, Thomas Stuckey, Chades Hansen, Denise Munoy, Debra VerSteeg, 
Mark Pulsipher, Navin Gupta, LeBauer Cardiovascular Research Foundation and Moses 
Cone Heart & Vascular Center, Greensboro, North Carolina. 
BACKGROUND: Primary PTCA has improved reperfusion rates in pts with AMI due to 
saphenous vein graft (SVG) occlusion, but procedural results remain suboptimal and the 
long term outlook has not been well defined. 
METHODS: Consecutive pts with AMI treated with primary PTCA from 1984-2000 
(N=1844) were prospectively enrolled in a registry and followed for 10 years. 
RESULTS: Pts with prior bypass surgery(CABG)(N=89) were more often men (81% vs. 
68%, p=0.01), had of prior MI (49% vs. 16%, p<0.001), cardiogenic shock (16% vs. 
7.3%, p=0.004), and 3 vessel CAD (82% vs. 20%, p<0.001), and less anterior MI (28% 
vs. 39%, p=O.04) and lower EF (47% vs. 52%, p=0.001). Pts with prior CABG achieved 
TIMI-3 flow less often (87% vs. 94%, p=0.007) and had higher 30-day mortality (14.6% 
vs. 7.6%, p=0.02). When the infarct artery was a SVG (N=54), TIMI-3 flow was achieved 
less frequently (80% vs. 94%, p<0.001) and 30-day mortality was higher (18.5% vs. 
7.6%, p=0.003). Late survival was worse in pts with SVG occlusion(figure). 
CONCLUSIONS: Pts with AMI due to SVG occlusion have higher early and substantially 
higher late mortality compared with pts with native vessel occlusion. The poor survival 
appears to be due to worse baseline risk profile, worse procedural results, and more 
rapid progression of disease over long term follow up. These should encourage the 
development of new procedural techniques and more aggressive secondary prevention 
in pts with SVG disease and a search for more durable revascularization strategies. 
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1075-29 Clinical end Angiographic Predictors of Abnormal 
Doppler-Derived Flow in the Infarct Related Artery After 
Primary Angioplaety for Acute Myocardial Infarction 
Simon R. Dixon, William W. O'Neill, John A. Fry, Robert D, Safian, James A. Goldstein, 
Cindy L. Grines, Terry R. Bowers, William Beaumont Hospital, Royal Oak, Michigan. 
Background. Abnormal phasic flow in the infarct related artery (IRA) after primary angio- 
plasty is associated with severe microvascular dysfunction and predicts poor recovery of 
left ventricutar function. Clinical and angiographic orrelates of an abnormal flow pattern 
in the IRA after primary angioplasty have not been well defined. 
Methods, Doppler derived coronary blood flow velocity patterns were recorded in the 
IRA after primary angioplasty or stenting in 78 patients with acute MI (mean age 63 ± 13 
JACC March 6, 2002 
yrs) utilizing an intracoronary Doppler wire (FIoWire, Endosonics). Abnormal flow was 
defined by the presence of rapid diastolic deceleration and early systolic flow reversal. 
Results. Fourteen patients (18%) had an abnormal flow pattern in the IRA after interven- 
tion despite an excellent angiographic result (TIMI-3 flow 100% pts, diameter stenosis 
<10%). The IRA was the left anterior descending (LAD) in 55%, right coronary artery in 
33%, and circumflex in 12%. Stenting was performed in 91% patients (POBA 9%). Base- 
line clinical characteristics, time-to-reperfusion from symptom-onset, prior thrembolytic 
therapy, and initial TIMl-flow grade did not correlate with the presence of an abnormal 
flow pattern. Compared to patients with a normal Doppler flow pattern, those with an 
abnormal flow pattern in the IRA after intervention were more likely to have LAD infarc- 
tion (30% vs. 3%, LAD vs. non-LAD, p=0.002), a lower left ventricular ejection fraction 
(35% vs. 47%, p=0.008), and a higher left ventricular end-diastolic pressure (31 vs. 
20mmHg, p<0.001).Concluslon. After primary PTCA, abnormal Doppler-derived phasic 
flow in the IRA is most commonly observed in patients with LAD occlusion. These data 
suggest that studies evaluating novel microvascular reperfusion therapies should prima- 
rily target patients with anterior wall infarction. 
1075-30 Corrected TIMI Frame Count (CTFC) and Quantitative 
Stress Myocardial Perfuslon imaging Defect Score 
Independently Predict Major Adverse Cardiac Events 
Following Successful Primary Angloplasty: A 
Dipyridemole Tc99m Sestamlbi Gated SPECT Imaging 
Study 
Satvendra Gid. Alan Ahlberg, Joseph Mitchel, Michael Gibson, Abdul Alkelyani, Jeffrey J. 
Popma, Deborah Katon, Andrew C. Eisenhauer, Gary V. Heller, Brigham & Women's 
Hospital, Boston, Massachusetts, Hartford Hospital, Hartford, Connecticut. 
Background: During primary angioplasty (PA), prolonged TIMI frame count (CTFC) may 
represent impaired microcirculation. Similarly, stress-induced MPI defects prognosticate 
adverse cardiac events (MACE). 
Methods: To investigate whether automated MPI score and CTFC correlate and predict 
MACE, we studied 58 consecutive pts treated with PA <12 hr of first acute MI (age 55+12 
yr., 74% male, symptom-to-balloon time: 269±72 min). Dipyddamole Tc 99m sestamibi 
MPI was performed 48 hrs post-procedure and at 6 weeks using 3-D MSPECT quantita- 
tive analysis software. Independent core laboratory performed quantitative angiography 
to determine CTFC and lumen dimensions. 
Results: Following PA, stress (28.4+20 vs 20.0~19; p<0.01 ) and rest MPI score (21.9±19 
vs 12.1+15; p<0.01) and LV ejection fraction (EF=47.3±10 vs 53.1+9; p=0.01) improved 
at 6 weeks. 
CTFC (mean 31.4±13) correlated with stress (r=0.79, p<0.0001; see figure) and rest 
(r=0.70, p<0.001) MPI defect score and LVEF (r=0.69, p<0.001). 
At one year, MACE occurred in 9 pts (1 death, 5 MI, 5 target vessel revascutarization). 
In multivariable analysis, MACE was predicted by quantitative stress MPI score [OR 0.54 
95%CI (0.34 - 0.86); p=0.01] and CTFC [OR 1.47 95% CI (1.12 - 1.92); p=0.005] with an 
important interaction between the two [OR 0.98 95%CI (0.97 - 0.99); p=0.01] 
Conclusion: The occurrence of slow flow (CTFC) and high stress MPI defect score fol- 
lowing PA, despite successful epicardial arterial patency, are independently associated 
with increased MACE. 
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1075-43 Role of Abciximab in the Preservation of Myocardial 
Mlcrocirculation During Mechanical Reperfusion for 
Acute ST Segment Elevation Myocardial Infarction 
Mahesh S. Mulumudi. Srinivasa P, Potiuri, Christopher J. White, Ochsner Medical 
Institutions, New Orleans, Louisiana. 
Objective: We investigated the effect of abciximab on myocardial microcirculation follow- 
ing primary coronary intervention for acute ST-segment elevation myocardial infarction 
(STEMI). 
Background: Prompt restoration of both epicardial blood flow and myocardial microcircu- 
lafion are the goals of reperfusion strategies in acute myocardial infarction. Myocardial 
Blush Grade (MBG) has been shown to be an important angiographic tool for the assess- 
ment of myocardial microcirculation reperfusion. Higher blush grades were associated 
with better outcomes. One possible mechanism by which abciximab exerts its beneficial 
